HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Water-Resistant Sunscreen Claims; OGX Recall; “Brightening” Hair Care; More

This article was originally published in The Rose Sheet

Executive Summary

SolRx petitions FDA to allow water-resistant sunscreen claims beyond the 80-minute cap established in the agency’s 2011 final rule. More news in brief.

You may also be interested in...



CIR Panel Affirms Hydroquinone Safety, Questions Use Under UV Nail Lights

At its September meeting, the Cosmetic Ingredient Review Expert Panel concluded that hydroquinone and p-hydroxyanisole are safe in gel nail products when LED lights are used in the curing process, but advises use of protective measures when UV lights, or fluorescent lights, are used due to concerns about skin-cancer risks. Separately, panel members issued a final amended assessment for preservative methylisothiazolinone, affirming their earlier tentative decision on the ingredient’s safety in rinse-off and leave-in products.

Fast-Growing Glop & Glam To Cuddle With SoCozy In Children’s Hair Care

While recent sales declines in children’s hair care speak to challenges in the segment, brands such as Glop & Glam have carved out successful niches – particularly in the salon channel. Newcomer SoCozy hopes to make a similar impression with its line of kids’ hair-care products with “a cool urban flair.”

Lornamead To Settle With FTC Over Deceptive Lice-Prevention Claims

Firm lacks scientific evidence for the claim that its Lice Shield shampoo and spray products reduce risk of lice infestation by more than 80%, among other statements made in advertisements and on product labeling. Under the terms of a proposed settlement, Lornamead will pay $500,000 to FTC and refrain from using unsupported claims or misrepresenting tests, studies or research in the context of product marketing.

Related Content

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS019219

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel